Growth in Children Affected by HIV

Area of Science:

• Pediatrics
• Infectious Diseases
• Growth and Development

Background:

• Children exposed to HIV in utero (CHEU) and children born with HIV (CHIV) are at risk for adverse growth outcomes.
• Growth impacts can manifest prenatally, including preterm birth, low birthweight, and being small for gestational age.
• CHIV exhibit more significant growth differences compared to CHEU, though early antiretroviral therapy (ART) improves outcomes.

Purpose of the Study:

• To highlight the distinct growth vulnerabilities of CHIV and CHEU.
• To emphasize the importance of vigilant growth monitoring for these pediatric populations.
• To inform pediatricians about potential drivers of growth disparities in children affected by HIV exposure.

Main Methods:

• This study is a review of existing literature on growth outcomes in children exposed to HIV.
• Analysis of growth data comparing CHIV and CHEU populations.
• Identification of factors contributing to growth disparities, including infection susceptibility and socioeconomic factors.

Main Results:

• Children exposed to HIV in utero are more likely to experience adverse birth outcomes like prematurity and low birthweight.
• CHIV demonstrate greater growth deficits than CHEU, but ART initiation leads to improved growth trajectories.
• CHEU remain susceptible to postnatal growth challenges due to factors like infection and socioeconomic vulnerabilities.

Conclusions:

• Pediatricians must recognize and address the unique growth needs of both CHIV and CHEU.
• Comprehensive growth assessment and management are crucial for children with in utero HIV exposure.
• Understanding multifaceted causes of growth disparities is key to ensuring children reach their full growth potential.